Fine Treatment, an Oxford-based healthcare company, has designed and tested through clinical trials its unique and easy-to-wear medical devices, called Dr Allen’s Devices. The indications include low back pain, benign prostate enlargement (BPE), pelvic pain due to chronic prostatitis, and kidney stones, which can be successfully dissolved with their patented treatment without renal colic.
Over 12 years ago, Fine Treatment embarked on a mission to bring their unique non-surgical medical products and Thermobalancing therapy to market and pressed ahead with patenting this treatment to improve patient safety relating to different health conditions.
Dr Allen’s Devices enable Fine Treatment to improve patient care and quality of life by supplying these innovative Thermobalancing therapy solutions to global healthcare systems, which are facing some of the most pressing challenges of the modern era.
During the COVID-19 pandemic, Thermobalancing therapy has helped many people to stay at home and avoid getting the virus in hospitals, as Dr Allen’s Devices provide an excellent at-home treatment for prostate enlargement (BPE or BPH), chronic prostatitis and pelvic pain, low back pain, and kidney stones of any type and size.
Ariana Adjani, Co-Founder of Fine Treatment, has presented new efficacy data obtained through pioneering R&D and clinical studies at several international medical conferences, including LSX World Congress and Longevity Leaders World Congress. It has been shown that Thermobalancing therapy increases healthy life expectancy.
Clinical trials on Thermobalancing therapy prove its effectiveness
Fine Treatment has successfully completed 4 clinical trials involving patients with enlarged prostate (BPH), inflamed prostate (chronic prostatitis), kidney stones in one or both kidneys, and chronic low back pain due to herniated disc (slipped disc in the spine) and persistent low back pain without any obvious cause.
Registered with the World Health Organisation, these clinical studies on Thermobalancing therapy and Dr Allen’s Devices confirm their remarkable safety and effectiveness.
- Dr Allen’s Device is the world’s first BPH treatment able to reduce the size of enlarged prostate naturally without surgery and medications, and relieve nasty urinary symptoms (LUTS), such as nocturia and having to pee frequently.
- With Dr Allen’s Device, a full recovery or a major reduction in the troubling symptoms can be achieved by patients with chronic prostatitis / chronic pelvic pain syndrome when antibiotics or other medications have been unable to help.
- Dr Allen’s Device enables men and women with kidney stone disease to dissolve kidney stones without surgical or removal procedures, such as extracorporeal shock wave lithotripsy (ESWL) and percutaneous nephrolithotomy (PCNL).
- Low back pain relief can be achieved with the use of Dr Allen’s Device even by patients with long-lasting pain arising from lumbar disc herniation and other causes without drugs and surgical procedures.
Dr Allen’s Devices are safe and side-effect-free
The effectiveness of this treatment is achieved through the improvement of blood microcirculation in the affected areas of the body by wearing Dr Allen’s Device over a prolonged period of time. It is designed to fit comfortably and does not impede movement.
These features make Dr Allen’s Device a superb at-home treatment. Dr Allen’s Device has been registered with the British medical healthcare agency (MHRA) since 2010, so its safety is confirmed, regulated, and has been well tested for over the decade. And it’s USPTO-patented.
About Fine Treatment
Fine Treatment https://finetreatment.com/ conducts innovative healthcare research and development and enables the use of Dr Allen’s Devices across the globe. Fine Treatment is the UK Department for International Trade registered supplier. To date, thousands of customers have chosen Dr Allen’s Device to enjoy the flexibility of this effective treatment at home.
Advertising disclosure: We may receive compensation for some of the links in our stories. Thank you for supporting LA Weekly and our advertisers.